Skip to Content

What is the difference between Mvasi and Avastin?

Medically reviewed by Last updated on Sep 16, 2019.

Official Answer


Mvasi (bevacizumab-awwb) is a biosimilar to Avastin (bevacizumab). However, Mvasi is not an interchangeable product with Avastin; the physician must write a prescription specifically for it.

A biosimilar, according to the FDA, is a biological product that is highly similar to an FDA-approved biological product, known as a reference product (in this case Avastin), and has no clinically meaningful differences in terms of safety and effectiveness.

Both Mvasi and Avastin are indicated for multiple types of cancer, including metastatic colorectal cancer, non-squamous non-small cell lung cancer, brain cancer (glioblastoma), metastatic renal cell carcinoma (kidney cancer) and cervical cancers.

See also: Comparing Avastin vs Mvasi

Related Medical Questions

Drug Information

Related Support Groups